Company Filing History:
1 out of 76 
1 out of 2,077 
1 out of 363 
Years Active: 2008-2010
Title: A Spotlight on Inventor Taxiarchis M Georgiadis
Introduction
Taxiarchis M Georgiadis, an accomplished inventor based in Carmel, Indiana, has made significant contributions to the field of pharmaceutical innovation. With a total of three patents to his name, his work primarily revolves around inhibitors that target specific protein tyrosine kinases, essential for various therapeutic applications.
Latest Patents
Among his recent inventions, Georgiadis has developed groundbreaking compounds that inhibit c-fms kinase activity. His notable patents include formulations identified as Formula II and Formulae I, II, and III. These compounds possess unique characteristics, which are detailed in the specifications, encompassing solvates, hydrates, tautomers, or pharmaceutically acceptable salts. The invention aims to provide significant advancements in the treatment of various diseases by effectively targeting and inhibiting protein tyrosine kinases, specifically c-fms kinase.
Career Highlights
Throughout his career, Taxiarchis Georgiadis has gained invaluable experience working with prominent companies in the pharmaceutical industry. His tenure at 3-Dimensional Pharmaceuticals, Inc. and Janssen Pharmaceutica N.V. has allowed him to hone his expertise in drug development and innovation. These roles have positioned him as a pivotal figure in the pursuit of new therapeutic options.
Collaborations
Georgiadis has had the pleasure of collaborating with several esteemed colleagues, including Mark R. Player and Nand Baindur. These partnerships have enriched his research endeavors and have contributed to the success of his innovative projects.
Conclusion
In summation, Taxiarchis M Georgiadis stands out as a prominent inventor in the realm of pharmaceutical research. With his innovative patents targeting c-fms kinase, he continues to be at the forefront of impactful drug development. His collaborative spirit and dedication to innovation solidify his status as a key contributor to the field, promising advancements that may change the landscape of therapeutic interventions.